Remission of psoriasis after chemotherapy for hematological malignancy

Article Sidebar

PDF (Español (España))
Published: Oct 4, 2024
Keywords:
psoriasis lymphoma chikungunya

Main Article Content

María Noemí da Ponte Rojas
Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas
Judith Nelsi Montiel Centurion Montiel Centurion
Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas
Claudia Romina Contreras Ramírez Contreras Ramírez
Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas
Arnaldo Benjamín Feliciano Aldama Caballero
Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas

Abstract

We report the case of a patient with psoriasis vulgaris who presented worsening of the disease after infection with Chikungunya, with no improvement of the outbreak with the usual treatment for psoriasis, in whom a diagnosis of classic Hodgkin lymphoma was subsequently made. Chemotherapy treatment was started and a complete improvement of the skin lesions of psoriasis was observed.

Article Details

How to Cite
1.
da Ponte Rojas MN, Montiel Centurion JN, Contreras Ramírez CR, Aldama Caballero ABF. Remission of psoriasis after chemotherapy for hematological malignancy. Rev. Nac. (Itauguá) [Internet]. 2024 Oct. 4 [cited 2024 Nov. 21];16(3):229-36. Available from: https://revistadelnacional.com.py/index.php/inicio/article/view/188
Issue
Vol. 16 No. 3 (2024): Revista del Nacional (Itauguá)
Section
Caso Clínico
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

Grän F, Kerstan A, Serfling E, Goebeler M, Muhammad K. Current developments in the immunology of psoriasis. Yale J Biol Med. 2020;93(1):97-110.

Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20(18):4347. doi: 10.3390/ijms20184347

Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB. The risk of lymphoma in patients with psoriasis. J Invest Dermatol. 2006;126(10):2194-201. doi: 10.1038/sj.jid.5700410.

Van Den Bosch C. A Role for RNA viruses in the pathogenesis of Burkitt’s Lymphoma: the need for reappraisal. Adv Hematol. 2012;2012:1-16. doi: 10.1155/2012/494758.

Chien YW, Wang CC, Wang YP, Lee CY, Perng GC. Risk of leukemia after dengue virus infection: a population-based cohort study. Cancer Epidemiol Biomarkers Prev. 2020;29(3):558-64. doi: 10.1158/1055-9965.EPI-19-1214.

Seetharam KA, Sridevi K. Chikungunya infection: a new trigger for psoriasis. J Dermatol. 2011;38(10):1033-4. doi: 10.1111/j.1346-8138.2011.01200.x.

Yoshida K, Kurosaka D, Ozawa Y, Yokoyama T, Tajima N. A case of rheumatoid arthritis associated with autoimmune hemolytic anemia due to weekly low-dose methotrexate therapy. Ryumachi Rheum. 2000;40(4):693-8.

Woolley III P, Sacher V, Priego V, Schanfield M, Bonnem E. Methotrexate-induced immune haemolytic anaemia. Br J Haematol. 1983;54(4):543-52. doi: 10.1111/j.1365-2141.1983.tb02132.x.

Arias de la Vega F, Torres López A, Piedra Roset P, Barco Burguete A, Rosas Gutiérrez L, Sola Galarza A. Anemia hemolítica paraneoplasica asociada a cáncer de próstata: a propósito de un caso. An Sist Sanit Navar. 2022;45(3):e1023.

Daudén E, Castañeda S, Suárez C, García-Campayo J, Blasco AJ, Aguilar MD, et al. Abordaje integral de la comorbilidad del paciente con psoriasis. Actas Dermosifiliogr. 2012;103(Supl 1):1-64.

Alballa N, Alyousef A, Alamari A, Alhumidi AA, Zayed MA, Zeitouni L, et al. Hodgkin’s lymphoma in a patient on adalimumab treatment for psoriasis. AME Case Rep. 2018;2(49):1-5.

Puig L, Notario J, López-Ferrer A, Scheneller-Pavelescu L, Pérez B, Galache C, et al. Recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología sobre el manejo de la psoriasis en pacientes oncológicos. Actas Dermosifiliogr. 2024;115(7):702-11.